Clinical Trial Update: Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating induction chemotherapy with durvalumab followed by durvalumab with radiotherapy in large-volume stage III non-small cell lung cancer; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (unspecified)
• Durvalumab (durvalumab)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Non-small Cell Lung Cancer Stage III | Phase 2 | Status: TERMINATED